ImMage Biotherapeutics' Seed Round

ImMage Biotherapeutics raised a round of funding on March 10, 2016. Investors include Coventry International.

Immage Therapeutics is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. The Company's pipeline is built from a proprietary portfolio of a…

Articles about ImMage Biotherapeutics' Seed Round: